<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2022.856779</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Effects of Probiotics and Prebiotics on Gut Pathogens and Toxins</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kong</surname> <given-names>Qing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/110067/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Tongjie</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1135719/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Xiao</surname> <given-names>Hang</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/739003/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>School of Food Science and Engineering, Ocean University of China</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Food Science, University of Massachusetts Amherst</institution>, <addr-line>Amherst, MA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Giovanna Suzzi, University of Teramo, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Paola Mattarelli, University of Bologna, Italy</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Qing Kong <email>kongqingg&#x00040;163.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Food Microbiology, a section of the journal Frontiers in Microbiology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>856779</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>02</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Kong, Liu and Xiao.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Kong, Liu and Xiao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/17649/effects-of-probiotics-and-prebiotics-on-gut-pathogens-and-toxins" ext-link-type="uri">Editorial on the Research Topic <article-title>Effects of Probiotics and Prebiotics on Gut Pathogens and Toxins</article-title></related-article>
<kwd-group>
<kwd>probiotics</kwd>
<kwd>prebiotics</kwd>
<kwd>mechanism</kwd>
<kwd>gut health</kwd>
<kwd>microbiota</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="4"/>
<page-count count="2"/>
<word-count count="973"/>
</counts>
</article-meta>
</front>
<body>
<p>Probiotics are &#x0201C;live microorganisms that, when administered in adequate amounts, confer a health benefit on the host&#x0201D; (Hill et al., <xref ref-type="bibr" rid="B3">2014</xref>). Specific strains especially those from <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> have been introduced as probiotics and have been consumed throughout the world. Probiotics can regulate the microecological balance of the digestive tract, inhibit the growth and adhesion of pathogenic bacteria, and ameliorate inflammation, thereby supporting a healthy digestive tract. Prebiotics are substrates that are selectively utilized by host microorganisms conferring a health benefit and they can also defense against pathogens and modulate gut microbiota (Gibson et al., <xref ref-type="bibr" rid="B2">2017</xref>). Use of some probiotics and prebiotics is endorsed by robust efficacy evaluations. However, our knowledge on their mechanisms is mainly based on research using <italic>in vitro</italic>, animal or <italic>ex vivo</italic> human models and not all mechanisms have been confirmed in humans (Pujari and Banerjee, <xref ref-type="bibr" rid="B4">2021</xref>).</p>
<p>Probiotics and prebiotics function in the intestine <italic>via</italic> crosstalk with the host and the commensal bacteria in certain ways, which, till now, are not fully understood regarding the specific molecules directly conferring the health benefits, the host targets of these molecules and the signal transduction pathways. The current understanding of the interactions between probiotics, prebiotics, microbiota, and pathogens in the gut is insufficient, which limits the application of probiotics and prebiotics (Cunningham et al., <xref ref-type="bibr" rid="B1">2021</xref>).</p>
<p>We received 14 submissions in this Research Topic, and finally seven research articles and one review passed the strict peer review process and were accepted for publication. The studies in this Research Topic show that the function of probiotics occurs mainly in the intestine. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2021.642549">Rodr&#x000ED;guez-Sorrento et al.</ext-link> confirmed that multi-strain probiotic (<italic>Bifidobacterium longum</italic> subsp. <italic>infantis</italic> CECT 7210 and <italic>Lactobacillus rhamnosus</italic> HN001) with or without galacto-oligosaccharides fought against enterotoxigenic <italic>Escherichia coli</italic> F4 in an early weaned piglet model. Research of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2021.705758">Wang Y. et al.</ext-link> showed that dietary <italic>Lactobacillus plantarum</italic> P8 supplementation improved the growth performance as well as the intestinal health of broilers infected with <italic>Eimeria</italic>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2021.722171">Wang T et al.</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2021.741391">Ast&#x000F3; et al.</ext-link> found probiotics had potential application to treat alcoholic liver disease induced by liquor and functional gastrointestinal disorders, respectively. Furthermore, the results from <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2021.755083">Ke et al.</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2021.716761">Buddhasiri et al.</ext-link> showed the effects of probiotics in controlling pathogens infection, such as <italic>Cronobacter</italic> spp. and <italic>Salmonella</italic>. Other functions of probiotics have attracted more and more attention, such as the antifungal effect shown by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2021.696267">Somashekaraiah et al.</ext-link> More and more researches showed that the marine active substances act beneficial effects on animals&#x00027; health through the intestine. The modulating effect of astaxanthin on gut microbiota has been reported by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2021.671271">Gao et al.</ext-link> in this Research Topic. These studies have expanded our understanding on this Research Topic; however, further studies are still needed to fully elucidate the underlying mechanisms.</p>
<sec id="s1">
<title>Author Contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s2">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname> <given-names>M.</given-names></name> <name><surname>Azcarate-Peril</surname> <given-names>M. A.</given-names></name> <name><surname>Barnard</surname> <given-names>A.</given-names></name> <name><surname>Benoit</surname> <given-names>V.</given-names></name> <name><surname>Grimaldi</surname> <given-names>R.</given-names></name> <name><surname>Guyonnet</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Shaping the future of probiotics and prebiotics</article-title>. <source>Trends Microbiol</source>. <volume>29</volume>, <fpage>667</fpage>&#x02013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2021.01.003</pub-id><pub-id pub-id-type="pmid">33551269</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname> <given-names>G. R.</given-names></name> <name><surname>Hutkins</surname> <given-names>R.</given-names></name> <name><surname>Sanders</surname> <given-names>M. E.</given-names></name> <name><surname>Prescott</surname> <given-names>S. L.</given-names></name> <name><surname>Reimer</surname> <given-names>R. A.</given-names></name> <name><surname>Salminen</surname> <given-names>S. J.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics</article-title>. <source>Nat. Rev. Gastroenterol. Hepatol</source>. <volume>14</volume>, <fpage>491</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2017.75</pub-id><pub-id pub-id-type="pmid">28611480</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname> <given-names>C.</given-names></name> <name><surname>Guarner</surname> <given-names>F.</given-names></name> <name><surname>Reid</surname> <given-names>G.</given-names></name> <name><surname>Gibson</surname> <given-names>G. R.</given-names></name> <name><surname>Merenstein</surname> <given-names>D. J.</given-names></name> <name><surname>Pot</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic</article-title>. <source>Nat. Rev. Gastroenterol. Hepatol</source>. <volume>11</volume>, <fpage>506</fpage>&#x02013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2014.66</pub-id><pub-id pub-id-type="pmid">24912386</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pujari</surname> <given-names>R.</given-names></name> <name><surname>Banerjee</surname> <given-names>G.</given-names></name></person-group> (<year>2021</year>). <article-title>Impact of prebiotics on immune response: from the bench to the clinic</article-title>. <source>Immunol. Cell Biol.</source> <volume>99</volume>, <fpage>255</fpage>&#x02013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1111/imcb.12409</pub-id><pub-id pub-id-type="pmid">32996638</pub-id></citation></ref>
</ref-list> 
</back>
</article>